Emcure reduces price of weight management drug Poviztra by 55%
Emcure reduces price of weight management drug Poviztra by 55% April 02, 2026 | Thursday | News Price…
Obesity, sleep, smoking, and inactivity show the strongest links to hypertension in U.S. adults
A national U.S. analysis shows that weight, sleep, smoking, and exercise habits may matter more for hypertension than…
All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
Fiber supplement stabilizes blood sugar in gestational diabetes
A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births…
Time-restricted eating improves hormone levels in women with PCOS
Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when…
Obesity Beyond GLP-1s: Oral Formulations Take Center Stage – Citeline News & Insights
Obesity Beyond GLP-1s: Oral Formulations Take Center Stage Citeline News & InsightsWeight loss drug frenzy: What’s here and what’s…
Split Protein Builds the Infrastructure for Weight Loss
Summary: While current weight-loss blockbusters like GLP-1s focus on suppressing appetite, researchers have uncovered a completely different strategy:…
Hormonal contraception not associated with prevalence of idiopathic intracranial hypertension
Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased prevalence of…
Wholegrain rye changes gut bacteria and lowers inflammation in obesity trial
A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
Atrogi begins human trial for muscle-preserving weight loss
Swedish biotech doses first subjects in new ATR-258 study, betting that the next big obesity breakthrough will be…